Two reports from The Jerusalem Post, from the country that was the first to start mass vaccination and now has the highest percentage of 'fully vaccinated' in the world: 62%. That was the percentage once mentioned in connection with herd immunity. I propose to call the 'fully vaccinated' people after the third injection 'abundantly vaccinated' otherwise it will become confusing. What do these vaccinations actually do and do they indeed appear to be 'the only way out' in Israel?
If you have read both messages, you know that ivermectin works better against the spread of corona than mass vaccination of the entire population, despite the irreversible injection of children, toddlers, toddlers and babies.
Post 1: Israeli scientist says COVID-19 can be treated for less than $1 a day
In summary: An Israeli researcher has conducted a study (double-blind randomized placebo controlled) into the effectiveness of ivermectin, which can be read on Medrkhiv.
- Only 13% of the ivermectin patients were still contagious after six days, compared to 50% of the placebo group - almost four times as many.
- Four placebo patients required hospital treatment, compared to only one ivermectin user, who was discharged from hospital a day later.
[Note 1: The study has not yet been peer reviewed and will undoubtedly be debunked because the sample is again considered too small: 89 subjects in total. No budget is available for an extensive trial with thousands of test subjects, which normally comes from parties that have a commercial interest in it: pharmaceutical companies. ]
[Note 2: In the lead-up to co-producing Covid vaccines, Merck, owner of ivermectin, has officially stated that there are safety concerns with this Nobel Prize-winning drug. This same Merck drug has been prescribed to billions of people without any problems. Read more about it here scheming from Merck to eliminate ivermectin in favor of vaccines. The current vaccines are temporarily permitted due to the state of emergency that has arisen because there is no medication. Major research is therefore not possible, also because pharmaceuticals have a great lobby in governments and advisory bodies.]
Click here for more virus varia articles on ivermectin
Link to Post 1 in The Jerusalem Post, translation at the bottom of this post
Post 2: COVID: New Restrictions Introduced – Is Israel Going into Lockdown?
The Green Pass is being reintroduced - also for children under 12! Mouth masks apparently help in Israel because they are also becoming mandatory again, including at outdoor gatherings. All this because of less than 4% positives among the 113,723 tests. Wasn't that close to the false-positive margin of PCR testing in a low-prevalence population? In any case: the country with the highest complete vaccination rate in the world is preparing for a new lockdown. Apparently vaccination does not buy your freedom.
For guidance on how the Covid cases have been going since July 1. I have included the Netherlands for comparison and India because we hear so little about how the terrible Covid monster is doing things there.
Link to Post 2 in The Jerusalem Post, translation at the bottom of this post
TRANSLATIONS FROM THE JERUSALEM POST
ARTICLE 1: Israeli scientist says COVID-19 can be treated for less than $1 a day
Double-blind study shows that ivermectin reduces the duration and contagiousness of the disease • FDA and WHO warn against its use
Door MAIAN JAFFE-HOFFMAN AUGUST 2, 2021 9:01 PM
Ivermectin, a drug used to fight parasites in Third World countries, could help shorten the duration of infection for people who contract the coronavirus for less than $1 a day, according to recent research by Sheba Medical Center in Tel Hashomer.
Prof. Eli Schwartz, founder of the Center for Travel Medicine and Tropical Disease in Sheba, conducted a randomized, controlled, double-blind study from May 15, 2020 to the end of January 2021 to evaluate the effectiveness of ivermectin in reducing viral shedding. among non-hospitalized patients with mild to moderate COVID-19.
Ivermectin has been approved by the U.S. Food and Drug Administration since 1987. The drug's discoverers received the Nobel Prize in Medicine in 2015 for treating onchocerciasis, a disease caused by infection with a parasitic roundworm.
Over the years it has been used for other indications including scabies and head lice. Additionally, over the past decade, several clinical trials have begun to demonstrate its antiviral activity against viruses ranging from HIV and influenza to Zika and West Nile.
The drug is also extremely economical. A study published in the peer-reviewed American Journal of Therapeutics showed that the cost of ivermectin for other treatments in Bangladesh is about $0.60 to $1.80 for a five-day course. It costs up to $10 a day in Israel, Schwartz said.
In Schwartz's study, approximately 89 eligible volunteers over the age of 18 diagnosed with the coronavirus and staying in state-run COVID-19 hotels were divided into two groups: 50% received ivermectin and 50% received a placebo, depending on their weight. They were given the pills three days in a row, one hour before meals.
The volunteers were tested with a standard nasopharyngeal swab PCR test with the aim of evaluating whether there was a reduction in viral load on the sixth day - the third day after the end of treatment. They were cleaned every two days.
Nearly 72% of volunteers treated with ivermectin tested negative for the virus on day six. In contrast, only 50% of those given the placebo tested negative.
ADDITIONALLY, the study looked at culture viability, meaning how contagious the patients were, and found that only 13% of ivermectin patients were contagious after six days, compared to 50% of the placebo group - almost four times as many.
Only 13% of the ivermectin patients were still contagious after six days, compared to 50% of the placebo group - almost four times as many.
"Onze studie toont in de eerste plaats aan dat ivermectine antivirale activiteit heeft," zei Schwartz. “Het laat ook zien dat er bijna 100% kans is dat een persoon binnen vier tot zes dagen niet-infectieus is, wat kan leiden tot het verkorten van de isolatietijd voor deze mensen. Dit kan een enorme economische en sociale impact hebben.”
The study appeared on the MedRxiv site with pre-prints of health research. It has not yet been peer-reviewed.
Schwartz said other similar studies — although not all conducted to the same double-blind and placebo standards as his — also showed a beneficial effect of ivermectin treatment.
His research did not prove that ivermectin was effective prophylactically, meaning it could prevent disease, he cautioned, nor did it show that it reduces the risk of hospitalization. However, other studies have shown such evidence, he added.
De studie die eerder dit jaar in het American Journal of Therapeutics werd gepubliceerd, benadrukte bijvoorbeeld dat “een beoordeling door de Front Line COVID-19 Critical Care Alliance de bevindingen samenvatte van 27 onderzoeken naar de effecten van ivermectine voor de preventie en behandeling van COVID-19-infectie , en concludeerde dat ivermectine 'een sterk signaal van therapeutische werkzaamheid vertoont' tegen COVID-19."
"Een ander recent onderzoek wees uit dat ivermectine het aantal sterfgevallen met 75% verminderde", aldus het rapport.
BUT IVERMECTIN is not without controversy and therefore, despite high levels of coronavirus worldwide, neither the FDA nor the World Health Organization were willing to approve it for use in the fight against the virus.
Prof. Ya'acov Nahmias, a researcher from the Hebrew University of Jerusalem, has questioned the drug's safety.
"Ivermectine is een chemisch therapeutisch middel en er zijn aanzienlijke risico's aan verbonden", zei hij in een eerder interview. "We moeten zeer voorzichtig zijn met het gebruik van dit type medicatie om een virale ziekte te behandelen waarvan de overgrote meerderheid van het publiek zal herstellen, zelfs zonder deze behandeling."
During Schwartz's study, there were no signs of significant side effects in ivermectin users.
Only five patients were referred to hospitals, four of whom were in the placebo arm. One ivermectin patient went to the hospital on the day of recruitment complaining of shortness of breath. He continued with the ivermectin treatment and was returned to the hotel a day later in good condition.
De FDA zei op haar website dat het "meerdere meldingen ontving van patiënten die medische hulp nodig hadden en die in het ziekenhuis waren opgenomen na zelfmedicatie met ivermectine." De "FDA heeft ivermectine niet goedgekeurd voor gebruik bij de behandeling of preventie van COVID-19 bij mensen", aldus de FDA. "Ivermectine-tabletten zijn goedgekeurd in zeer specifieke doses voor sommige parasitaire wormen, en er zijn actuele (op de huid) formuleringen voor hoofdluis en huidaandoeningen zoals rosacea. Ivermectine is geen antiviraal middel (een geneesmiddel voor de behandeling van virussen). Het nemen van grote doses van dit medicijn is gevaarlijk en kan ernstige schade aanrichten.”
The World Health Organization has also recommended against using the drug except in clinical trials.
IN RESPONSE, Schwartz said he was very disappointed that the WHO did not support any trial to determine whether the drug could be viable. Last month, the University of Oxford announced a major study into the effectiveness of ivermectin.
Schwartz raakte ongeveer een jaar geleden geïnteresseerd in het onderzoeken van ivermectine, "toen iedereen op zoek was naar een nieuw medicijn" om COVID-19 te behandelen, en er veel moeite werd gedaan om hydroxychloroquine te evalueren, dus besloot hij mee te doen. "Omdat ivermectine op mijn plank lag, omdat we het gebruiken voor tropische ziekten, en er hints waren dat het zou kunnen werken, besloot ik ervoor te gaan," zei hij.
Rond dezelfde tijd begonnen onderzoekers op andere plaatsen over de hele wereld naar het medicijn te kijken. Maar toen ze positieve resultaten begonnen te zien, wilde niemand ze publiceren, zei Schwartz. "Er is veel tegenstand", zegt hij. “We probeerden het te publiceren, maar het werd weggegooid door drie tijdschriften. Niemand wilde er zelfs maar iets over horen. Je moet je afvragen hoe het komt dat de wereld lijdt. Dit medicijn zal geen grote economische winst opleveren", en dus wil Big Pharma er niets mee doen, zei hij.
SOME OF the loudest opposition to ivermectin comes from Merck Co., which produced the drug in the 1980s. In a public statement about ivermectin on its website in February, it said: "Company scientists continue to carefully examine the findings of all available and emerging studies of ivermectin for the treatment of COVID-19 for evidence of efficacy and safety. It is important to note that our analysis to date has found no scientific basis for a potential therapeutic effect against COVID-19 from preclinical studies; no meaningful evidence of clinical activity or clinical efficacy in patients with COVID-19 disease, and a concerning lack of safety data in most studies.”
But Merck has not launched its own research into ivermectin.
"Je zou denken dat Merck blij zou zijn te horen dat ivermectine nuttig zou kunnen zijn voor coronapatiënten en zou proberen het te bestuderen, maar ze verklaren het hardst dat het medicijn niet mag worden gebruikt", zei Schwartz. “Een miljard mensen namen het. Ze gaven het aan hen. Het is een echte schande. En als ivermectine niet verder gaat, kan de tijd die de wereld nodig heeft om naast het virus te leven, mogelijk langer duren".
“Het ontwikkelen van nieuwe medicijnen kan jaren duren; daarom kan het identificeren van bestaande medicijnen die opnieuw kunnen worden gebruikt tegen COVID-19 en die al een vastgesteld veiligheidsprofiel hebben gedurende tientallen jaren van gebruik, een cruciale rol kunnen spelen bij het onderdrukken of zelfs beëindigen van de SARS-CoV-2-pandemie”, schreven onderzoekers in het American Journal of Therapeutics. "Het gebruik van herbestemde medicijnen kan vooral belangrijk zijn, omdat het maanden, mogelijk jaren kan duren voordat een groot deel van de wereldbevolking is gevaccineerd, vooral onder bevolkingsgroepen met een laag tot gemiddeld inkomen."
ARTICLE 2: COVID: New restrictions introduced - will Israel lock down?
From August 8, the full green pass system will be in force again (from August 20 also for children under 12 years old), face masks will be mandatory at all outdoor gatherings.
Door ROSSELLA TERCATIN 4 AUGUST 2021 09:54
The coronavirus cabinet approved new restrictions on Tuesday evening, as the government indicated a September lockdown had become a real possibility.
From August 8, the full green pass system will come into effect again (from August 20 also for children under 12 years old), masks will be mandatory at all outdoor gatherings and vaccinated/recovered parents of a quarantined child under 12 years old will also be required to isolate. In addition, government agencies will operate with only 50% of their staff off-line, and the private sector will be encouraged to do the same.
In addition, stricter criteria will be formulated for placing countries under a travel ban or travel warning, allowing a very limited group of countries to be freely visited by Israelis without having to quarantine upon their return, regardless of their immunization status.
"De Delta-epidemie is buitengewoon besmettelijk en verspreidt zich over de hele wereld", zei premier Naftali Bennett. “Vermijd drukte en laat je vaccineren – nu. Anders zit er niets anders op dan strengere beperkingen op te leggen, waaronder een lockdown.”
"We moeten de bevolking en de publieke opinie voorbereiden op een lockdown in september, een maand waarin de economische schade minder zal zijn, en de immunisatie-inspanningen versnellen om te proberen deze te voorkomen", zei minister van Defensie Benny Gantz, verwijzend naar de periode van de Joodse feestdagen.
We must prepare the population and public opinion for a lockdown in September
Benny Gantz, Minister of Defense in Israel
Currently, the green pass, which only allows access to venues and activities to people who have been fully vaccinated, recovered or who have undergone a coronavirus test in the last 72 hours, only applies to gatherings of more than 100 people. The entire system will apply to multiple activities regardless of the number of participants.
In addition, the current green pass exemption for children under the age of 12 has been abolished.
On Monday, the country recorded more than 3,800 new cases in the past 24 hours, with 3.78% of 113,723 tests returning a positive result. Both figures are the highest since early March.
With the 10 people who died on Sunday and another seven on Monday, the country recorded the highest death toll in 48 hours in four months.
The number of serious patients stood at 221, nine more than the day before and 66 more than last Tuesday. Experts warn that the number is doubling every 10 days.
Also on Tuesday, Gantz announced that another 1,000 reservists will be recalled to support the ministry's activities related to the pandemic. Soldiers are deployed for various logistics activities.
In addition, 500 medics will be recruited to support the Ministry of Health's vaccination efforts.
The campaign to vaccinate people over 60 with a third injection continues at full speed. About 142,000 had already received it by Tuesday afternoon.
The two largest healthcare providers, Clalit and Maccabi, announced that another 180,000 and 125,000 of their members had booked an appointment.
"Iedereen zou moeten weten dat bijna 9 van de 10 ernstige patiënten ouder zijn dan 60", zei premier Bennett terwijl hij zijn moeder, Mirna, vergezelde om dinsdagochtend te worden ingeënt. “Het derde vaccin ‘laadt’ simpelweg de afweer van het lichaam op en stelt ons in staat levens te redden.”
"Ik zou zijn gekomen, zelfs als hij niet de premier was, omdat ik denk dat het echt belangrijk is voor ons allemaal", zei Mirna. “Oude mannen en vrouwen doen het, maar ik maak me zorgen om de jongeren die niet het eerste vaccin hebben gekregen. Ik wil bij mijn zoon zijn op Rosj Hasjana en op de bruiloft van mijn kleinzoon in oktober. Ik wil niet nog een lockdown.”
websites with overviews of ivermectin studies
